LKFT Lakefront Biotherapeutics
$31.82▲ +0.43%
Healthcare
Other
Volume 170.8K
Avg Volume (10D) 224.2K
Key Metrics & Fundamentals
Market Cap
$2.10B
P/E Ratio
3.0
Div Yield
0.00%
52W Range
25.68 - 36.24
% vs 50 MA
8.72%
% vs 200 MA
6.28%
RSI-14
67.4
MACD Histogram
+0.2000
Beta (1Y vs SPY)
0.61
Free Cash Flow
-$34.12M
Gross Rev
$12.11M
Gross Profit
$2.97M
EBITDA
$46.92M
COGS
$9.15M
Operating Exp
$46.48M
Operating Income
-$43.51M
EBIT
-$43.51M
Pretax Income
$2.01M
Net Income
$2.11M
Price & Volume History
Loading chart…
Recent News
Lakefront Biotherapeutics - Sponsored ADR (LKFT) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Oct 21, 2026 11:00 AM ET
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Looks Undervalued Despite A 40% Five Year Fall
Simply Wall St. · Oct 21, 2026 1:16 AM ET
Acquisition of Own Shares
GlobeNewswire · Oct 20, 2026 4:01 PM ET
Belgian startup revives Galapagos CAR-T research
BioPharma Dive · Oct 15, 2026 11:55 AM ET
Lakefront Biotherapeutics Sells Preclinical CAR-T Programs to Armed Cell Therapeutics
MT Newswires · Oct 14, 2026 4:23 PM ET
Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics
GlobeNewswire · Oct 14, 2026 4:01 PM ET
Acquisition of Own Shares
GlobeNewswire · Oct 13, 2026 4:01 PM ET
Lakefront Receives Transparency Notification From Bank of America
MT Newswires · Oct 8, 2026 4:32 PM ET
Lakefront Receives Transparency Notification from Bank of America
GlobeNewswire · Oct 8, 2026 4:01 PM ET
Acquisition of Own Shares
GlobeNewswire · Oct 6, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LKFT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.